Calliditas Therapeutics AB, announced that the U.S. Food and Drug Administration has accepted the submission for the supplemental New Drug Application for TARPEYO® delayed release capsules and granted Priority Review.
Calliditas Therapeutics AB, announced that the U.S. Food and Drug Administration has accepted the submission for the supplemental New Drug Application for TARPEYO® delayed release capsules and granted Priority Review.